Pamela G. Joseph

Pamela G. Joseph serves as a key procurement professional within the CDC Office of Acquisition Services, supporting the agency’s mission to safeguard public health through strategic acquisition of scientific, technical, and operational services. She manages a portfolio of complex contracts enabling laboratory diagnostics, infectious disease surveillance, and data-driven public health response capabilities. Her work centers on securing high-integrity professional services critical to CDC’s biomedical research, epidemiological analysis, and emergency preparedness infrastructure, ensuring alignment with federal acquisition regulations and mission-critical timelines. Joseph maintains enduring partnerships with leading contractors including General Dynamics Information Technology, GlaxoSmithKline, New York City Health & Hospitals Corp, Cepheid, and MRIGLOBAL. These relationships reflect a focus on high-capacity, mission-aligned vendors capable of delivering advanced diagnostics, clinical research support, and large-scale public health operational services. Her contracting approach emphasizes performance-based outcomes, technical rigor, and seamless integration with CDC’s scientific and operational workflows, often involving multi-year, task-order-based agreements under indefinite-delivery/indefinite-quantity (IDIQ) vehicles. Joseph’s procurement activities exhibit a strong preference for non-set-aside contracts, with 100% of awards issued under open competition. This reflects a strategic emphasis on maximizing technical capability and operational readiness over socioeconomic set-asides, prioritizing domain expertise and proven performance in high-stakes public health environments. Her primary procurement focus is on NAICS 541990 — All Other Professional, Scientific, and Technical Services — encompassing specialized contract research, bioinformatics, laboratory support, outbreak response analytics, and public health surveillance system development. She consistently procures advanced scientific services requiring deep technical proficiency in infectious disease modeling, molecular diagnostics, and real-time data integration, underscoring her expertise in the intersection of public health science and federal acquisition.